Innopharma s. r. o.

Active
IČO 43982417limited liability company (s.r.o.)Founded 2008Dunajská Streda

Key figures

28 091 396 €+18,4%
Revenue 2025
+17,9%
Average annual growth 2020–2025
010 m20 m30 m202020212022202320242025

Key figures

2025

Dividends

calculated
2025

Distributed as dividends 2 050 002 € (25 % of distributable profit).

History
20252 050 002 €
20241 540 001 €
20231 479 998 €
2022619 999 €
20211 519 250 €

Summary: Innopharma s. r. o.

What kind of company is it?

Innopharma s. r. o. (IČO 43982417) is a limited liability company (s.r.o.). The company was incorporated in 2008 and has existed for 18 years. Registered office according to the register: Dunajská Streda. Main activity according to the Statistical Office: výroba ostatných potravinárskych produktov i. n. (SK NACE 1089). Size category by number of employees: 100–149 employees.

Who runs the company and who owns it?

The company has one statutory representative. According to the register, the company has 2 shareholders. The registered capital is 20 668 €.

How is the company doing financially?

Revenue for 2025 was 28 091 396 €, up 18,4 % on the previous year (23 725 435 €). From 2020 to 2025, revenue grew by an average of 17,9 % per year. This is the highest revenue in the reported years (2020–2025). Net profit for 2025 was 5 497 636 € (19,6 % of revenue). The company was profitable in all 6 reported years. Personnel costs for 2025 were 4 032 829 €. At the end of 2025 the company had total assets of 15 954 256 € and equity of 11 714 796 € (equity ratio 73,4 %).

Where does the data come from and how current is it?

Company and people data come from the Register of Legal Entities (Statistical Office SR, CC BY 4.0) and financial statements from the Register of Financial Statements (Ministry of Finance SR); icoprofil.sk updates them daily. Data as of 21. 11. 2026. Changes, averages and ratios are calculated by icoprofil.sk from open data and are not an official assessment.

Summary of annual reports2020–2025
20212022202320242025
Revenue (net turnover)16 005 29615 976 47118 854 83523 725 43528 091 396
Profit for the reporting year2 105 8741 064 1611 448 0483 357 0895 497 636
Retained earnings of previous periods3 909 2535 395 1284 979 2914 887 3386 194 425
Total assets8 685 8758 819 4989 447 63613 257 68715 954 256
Total liabilities2 648 0132 337 4742 997 5624 990 5254 239 460
Total equity6 037 8626 482 0246 450 0748 267 16211 714 796
Calculated dividends1 519 250619 9991 479 9981 540 0012 050 002

A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.

Connections graph
96,37 %3,63 %directorInnopharma s. r. o.Innopharma s. r. o.PRINCIPLEHEALTHCARE INTERN…PRINCIPLE HEALTHCARE INTERNATIONAL LIMITEDEVP Group GmbHEVP Group GmbHPLPál Krisztián LangPál Krisztián Lang
PersonCompanyOwnership (thickness = share)Role in a bodyZoom: Ctrl/⌘ + wheel

The graph is based on entries in the Register of Legal Persons. Shares are calculated from shareholders' contributions; this is not a record of beneficial owners. Individuals are not linked across companies.

Documents in the Register of Financial Statements15

Documents open directly on registeruz.sk (Ministry of Finance of the Slovak Republic).

Similar companies

Same industry (SK NACE 1089)
Innopharma s. r. o. (IČO 43982417) – revenue 28,1M € | icoprofil.sk